Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL501741

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
O=C(OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1

Basic Information

ChEMBL ID CHEMBL501741
Phase Preclinical
Structure Type MOL
InChI Key QACZCPQDYIUXRV-WQECCOASSA-N
1
Targets
3
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

576.5
MW (Da)
0.53
ALogP
15
HBA
9
HBD
253.1
PSA (Ų)
0.14
QED
3
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

Natural Product First in Class Prodrug

Extended Properties

Molecular Formula C26H24O15
MW 576.46
Aromatic Rings 3
Heavy Atoms 41
NP-Likeness 1.26

Activity Summary

IC50 3 meas. best 6.55

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 6.55 6.0367 280.0 3

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 280.0 nM 6.55 Inhibition of HIV2 RNase H by FRET assay 18763827
Unchecked IC50 = 550.0 nM 6.26 Inhibition of human RNase H by FRET assay 18763827
Unchecked IC50 = 5050.0 nM 5.3 Inhibition of HIV1 RNase H by FRET assay 18763827

Literature References

PubMed DOI Target Context # Activities
18763827 10.1021/np8002518 Unchecked 4

Data from ChEMBL 36 via Core Engine